TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Bionordika AS
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
42,163
|
44,323
|
57,203 |
| Financial expenses |
427
|
770
|
729 |
| Earnings before taxes |
2,283
|
3,518
|
11,683 |
| Total assets |
19,705
|
18,005
|
28,184 |
| Current assets |
18,856
|
17,332
|
27,700 |
| Current liabilities |
11,543
|
10,614
|
19,941 |
| Equity capital |
6,969
|
7,272
|
8,040 |
| - share capital |
99
|
101
|
108 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
35.4%
|
40.4%
|
28.5% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
5.4%
|
7.9%
|
20.4% |
| Return on assets (ROA) |
13.8%
|
23.8%
|
44.0% |
| Current ratio |
163.4%
|
163.3%
|
138.9% |
| Return on equity (ROE) |
32.8%
|
48.4%
|
145.3% |
| Change turnover |
-1,375
|
-9,090
|
-14,673 |
| Change turnover % |
-3%
|
-17%
|
-20% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.